Non-Alcoholic Fatty Liver Disease (NAFLD): new challenge for general practitioners and important burden for health authorities?

[1]  L. Poston,et al.  Maternal high‐fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression , 2009, Hepatology.

[2]  Beverley Balkau,et al.  Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population , 2009, Hepatology.

[3]  Z. Younossi,et al.  Screening for hepatitis B, C and non‐alcoholic fatty liver disease: a survey of community‐based physicians , 2009, Alimentary pharmacology & therapeutics.

[4]  Christopher D Byrne,et al.  Metabolic disturbances in non-alcoholic fatty liver disease. , 2009, Clinical science.

[5]  C. Byrne,et al.  Current treatment of non‐alcoholic fatty liver disease , 2009, Diabetes, obesity & metabolism.

[6]  P. Portincasa,et al.  Improving nonalcoholic fatty liver disease management by general practitioners: a critical evaluation and impact of an educational training program. , 2008, Journal of gastrointestinal and liver diseases : JGLD.

[7]  M. Monami,et al.  Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. , 2008, Metabolism: clinical and experimental.

[8]  G. Lippi,et al.  Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients , 2008, Diabetologia.

[9]  C. Byrne,et al.  Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD). , 2007, Drug discovery today.

[10]  Khean-Lee Goh,et al.  How common is non‐alcoholic fatty liver disease in the Asia–Pacific region and are there local differences? , 2007, Journal of gastroenterology and hepatology.

[11]  Manisha Talim,et al.  Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients , 2007, Diabetes Care.

[12]  L. Bouter,et al.  Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. , 2007, Atherosclerosis.

[13]  Jeffrey B. Schwimmer,et al.  Prevalence of Fatty Liver in Children and Adolescents , 2006, Pediatrics.

[14]  G. Radetti,et al.  Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging. , 2006 .

[15]  D. Mozaffarian,et al.  Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States , 2006, Hepatology.

[16]  G. Targher,et al.  Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non‐alcoholic fatty liver disease , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[17]  Shi-yao Chen,et al.  Fatty liver and the metabolic syndrome among Shanghai adults , 2005, Journal of gastroenterology and hepatology.

[18]  G. Targher,et al.  Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. , 2005, Diabetes.

[19]  F. Carvalho,et al.  Body mass index and waist circumference in non-alcoholic fatty liver disease. , 2005, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[20]  Shi-yao Chen,et al.  Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. , 2005, Journal of hepatology.

[21]  Y. Iwamoto,et al.  Prevalence of non‐alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[22]  G. Bedogni,et al.  Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study , 2005, Hepatology.

[23]  S. Sanderson,et al.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.

[24]  C. Byrne,et al.  Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[25]  U. John,et al.  Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. , 2005, World journal of gastroenterology.

[26]  S. Grundy,et al.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. , 2005, American journal of physiology. Endocrinology and metabolism.

[27]  K. Tolman,et al.  Narrative Review: Hepatobiliary Disease in Type 2 Diabetes Mellitus , 2004, Annals of Internal Medicine.

[28]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[29]  C. Ahn,et al.  Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. , 2004, Archives of internal medicine.

[30]  E. Fassio,et al.  Natural history of nonalcoholic steathepatitis: A longitudinal study of repeat liver biopsies , 2004, Hepatology.

[31]  A. McCullough,et al.  The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. , 2004, Clinics in liver disease.

[32]  P Christoffersen,et al.  Long term prognosis of fatty liver: risk of chronic liver disease and death , 2004, Gut.

[33]  D. Akbar,et al.  Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic: prevalence and general characteristics. , 2003, Diabetes care.

[34]  James G Kench,et al.  Long‐term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C , 2003, Hepatology.

[35]  Jian-Gao Fan,et al.  Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. , 2003, World journal of gastroenterology.

[36]  P. Giral,et al.  Survival, liver failure, and hepatocellular carcinoma in obesity‐related cryptogenic cirrhosis , 2002, Hepatology.

[37]  R. Karim,et al.  NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome , 2002, Hepatology.

[38]  G. Pacini,et al.  Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association , 2002, Hepatology.

[39]  J. Dixon,et al.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. , 2001, Gastroenterology.

[40]  P. Jousilahti,et al.  Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. , 2000, Stroke.

[41]  G. Brandi,et al.  Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy , 2000, Annals of Internal Medicine.

[42]  K. Batts,et al.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis , 1999, Hepatology.

[43]  Z. Younossi,et al.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. , 1999, Gastroenterology.

[44]  S. Ebrahim,et al.  Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. , 1995, American journal of epidemiology.

[45]  F. Al-Mulhim,et al.  Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management. , 1992, The British journal of radiology.

[46]  J. Tulloch.  Myocardial infarction in Jamaica: the clinical features. , 1958, The West Indian medical journal.

[47]  L. N. Valenti,et al.  Carotid artery intima-media thickness in nonalcoholic fatty liver disease. , 2008, The American journal of medicine.

[48]  Mohamed H. Ahmed.  Biochemical markers: the road map for the diagnosis of nonalcoholic fatty liver disease. , 2007, American journal of clinical pathology.

[49]  G. Zoppini,et al.  Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled Type 2 diabetic patients , 2006, Journal of endocrinological investigation.

[50]  S. Wild,et al.  Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects , 2005, Diabetologia.

[51]  C. Byrne,et al.  Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes , 2005, Diabetologia.

[52]  Shohei Matsuzaki,et al.  Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background , 2003, Journal of Gastroenterology.